Skip to main content
. Author manuscript; available in PMC: 2022 Feb 12.
Published in final edited form as: J Asthma. 2020 Nov 19;59(2):223–229. doi: 10.1080/02770903.2020.1847932

Table 3:

Binary outcomes in patients admitted with a diagnosis of COPD or asthma and documented substance misuse compared to those without documented substance misuse.1

Outcome Adjusted Weighted OR (95% CI) P value
Intubation/Mechanical Ventilation 1.57 (1.47, 1.67) < 0.01
Respiratory failure 1.19 (1.14, 1.24) <0.01
Sepsis 1.20 (1.03, 1.40) 0.017
Encephalopathy 1.80 (1.56, 2.07) < 0.01
In hospital mortality 0.96 (0.81, 1.13) 0.63
1.

All adjusted ORs are adjusted for tobacco use disorder, alcohol misuse, age, gender, primary expected payer, median household income national quartile per zip code, patient location, hospital location, AIDS, deficiency anemias, rheumatoid arthritis/collagen vascular diseases, chronic blood loss anemia, congestive heart failure, coagulopathy, depression, diabetes, hypertension, hypothyroidism, liver disease, lymphoma, fluid and electrolyte disorders, metastatic cancer, other neurological disorders, obesity, paralysis, peripheral vascular disorders, psychoses, renal failure, solid tumor without metastasis, peptic ulcer disease excluding bleeding, valvular disease and weight loss.